Clinical outcomes after implantation of extended depth‑of‑focus AcrySo…
본문
Clinical outcomes after implantation
of extended depth‑of‑focus AcrySof® Vivity® intraocular lens
in eyes with low‑grade epiretinal membrane
of extended depth‑of‑focus AcrySof® Vivity® intraocular lens
in eyes with low‑grade epiretinal membrane
Sohee Jeon MD, PhD, Ayoung Choi BSc, Optom, Hyunggoo Kwon MD
낮은 등급의 망막전막이 있는 눈에
확장된 초점 심도(EDoF) AcrySof® Vivity® 렌즈 삽입 후 임상결과
[카이안과 의료팀] 전소희 원장, 최아영 검안사, 권형구 원장
Vivity 이식 이력이 있는 낮은 등급의 망막전막환자 45개의 눈과
원거리 시력과 선명도에서는
낮은 등급의 망막전막(ERM)이 있는 눈에
확장된 초점 심도(EDoF) AcrySof® Vivity® 렌즈를 삽입한 후
시력과 합병증 발생에 대한 임상 결과를 평가한 연구로,
Vivity 이식 이력이 있는 낮은 등급의 망막전막환자 45개의 눈과
Vivity 이식 이력이 있고 망막전막이 없는 50개의 연령 일치 대조군과 비교한 결과
원거리 시력과 선명도에서는
망막전막이 없는 눈과 다르지 않은 시력결과를 보였지만
근거리 중간거리 시력은 다소 낮게 나오는 것을 확인할 수 있었습니다.
연구결과, 새롭게 개발된 EDoF IOL(확장된 초점심도 렌즈)을 이용한 수술이
내측망막에 한해 낮은 등급의 망막전막(ERM)이 있는 눈에
도움이 될 수 있다는 것을 알 수 있었습니다.
Purpose
To evaluate the clinical outcomes of
To evaluate the clinical outcomes of
extended depth-of-focus (EDoF) AcrySof® Vivity® intraocular lens
in eyes with low-grade epiretinal membrane (ERM).
Methods
Forty-five eyes with low-grade ERM and history
Forty-five eyes with low-grade ERM and history
of Vivity implantation were compared
with 50 age-matched controls with Vivity implantation and no ERM.
Eyes with ERM showing widening of the outer nuclear layer
and loss of the foveal depression,
but no ectopic inner foveal layer or outer retinal defect were eligible.
Corrected and uncorrected distant visual acuity (CDVA and UDVA),
uncorrected intermediate and near visual acuity (UIVA and UNVA),
contrast sensitivity detected
by area under the log contrast sensitivity function (AULCSF), Strehl ratio,
area ratio, and occurrence of dysphotopsia were compared between groups.
Results
UDVA and CDVA were similar between groups (UDVA: 0.01 ± 0.05 vs
UDVA and CDVA were similar between groups (UDVA: 0.01 ± 0.05 vs
0.03 ± 0.06, P = 0.154; CDVA: 0.00 ± 0.00 vs 0.00 ± 0.02, P = 0.125).
UIVA and mesopic AULCSF were significantly worse in eyes
with ERM compared to those with no ERM
(UIVA: 0.09 ± 0.09 vs 0.14 ± 0.10, P = 0.028; mesopic AULCSF
: 1.26 ± 0.15 vs 1.17 ± 0.10, P = 0.013).
The occurrence of dysphotopsia was similar in both groups
(glare: P = 0.465; halo: P = 0.218; starburst: P = 0.457).
Discussion
Eyes with low-grade ERM showed comparable outcomes
Eyes with low-grade ERM showed comparable outcomes
to eyes without ERM after Vivity IOL implantation.
Implantation of this newly developed EDoF IOL with low addition can be of benefit to eyes
with low-grade, reversible ERM that is limited to the inner retina.
